Registry for health care research and quality assurance in private oncological practices

Recruiting

• Conditions: oncological and hematological diseases; C00-D48; Neoplasms

• Registration Number: DRKS00004818
• Lead Sponsor: rgb Onkologisches Management GmbH

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2013-04-26
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 35000

Inclusion Criteria

Patient with confirmed oncological / hematological diagnosis
- At least one oncological treatment
- Beginning of documented therapy must not be longer than 10 months.
- Declaration of consent

Exclusion Criteria

none

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary objective is the acquisition and representation of real-life treatment in the outpatient sector. Recorded variables are defined in the common single oncological basic data set of ADT /GEKID. Additionally, data of therapy regime and its change over time is collected. The entire therapy course of a Patient will be collected from diagnosis until death or for a five year period in adjuvant therapies each patient history including all therapies of a patient.<br>The following epidemiological surveys should be specified ubiquitously:<br>- Relative survival of cancer patients in Germany<br>- Penetration guideline-based therapies in oncology outpatient practice<br>- Definition of reference- or metadata<br>Furthermore, the possibility of defining reference intervals for measures (quality indicators) that could be used as the basis for quality management systems should be analyzed.<br>

Secondary Outcome Measures

Name	Time	Method
not relevant